Clinical Trial Update: Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study) [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 clinical trial evaluating adjuvant NSAID therapy for Graves' ophthalmopathy in Graves' disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease
• Graves Ophthalmopathy

Drugs mentioned

• Non-steroidal anti-inflammatory drug (NSAID) (NSAID)

Snippet

Sponsor: Mikael Lantz | Conditions: Graves´ Disease | Phase 4 | Status: COMPLETED